A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with locally advanced or metastatic solid tumors.
Invest New Drugs
; 39(1): 163-174, 2021 02.
Article
in En
| MEDLINE
| ID: mdl-32737717
Full text:
1
Database:
MEDLINE
Main subject:
Piperazines
/
Piperidines
/
Pyrimidines
/
Azetidines
/
Antineoplastic Agents
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Invest New Drugs
Year:
2021
Type:
Article
Affiliation country:
United States